Antikonvülzan İlaç Zehirlenmeleri

Gray LA. Anticonvulsant toxicity. Medicine. 2020; 48(3): 192-193.

McMillin GA, Jueiike JM, Johnson M et al. Discordant carbamazepine values between two immunoassays: carbamazepine values determined by ADVIA Centaur correlate better with those determined by PETINIA assay. J Clin Lab Anal 2011; 25: 212-216.

McMillin GA, Juenke JM, Tso G et al. Estimation of carbamazepine and carbamazepine 10, 11-epoxide concentrations in plasma using mathematical equa- tions generated with two carbamazepine immunoassays. Am J Clin Pathol 2010; 133; 728-736.

Parant F, Moulsma M, Gagnieu MC et al. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA). Ther Ding Monit 2005; 27: 457-462.

Klotz U. The role of pharmacogenomics in the metabolism of antiepileptic dings: pharmacokinetics and therapeutic implications. Clin Phannacokinet 2007: 46:271-279.

McMillin GA, Jueiike JM, Johnson M et al. Discordant carbamazepine values between two immunoassays: carbamazepine values determined by ADVIA Centaur correlate better with those determined by PETINIA assay. J Clin Lab Anal 2011; 25: 212-216.

Kemper EM, van Khan HJ, Speelman P et al. Severe phenytoin intoxi- cation in patients with hypoalbuminemia [in Dutch], Ned Tjdschr Geneeskd 2007; 151: 138-141.

Wolf GK. McClain CD, Zurakoski D et al. Total phenytoin concentra- tions do not accurately predict free phenytoin concentrations in critically ill children. Pediatr Crit Care Med 2006; 7: 434-439.

Dasgrupta A. (2018).Toksi̇koloji̇ ve terapöti̇k ilaç izlemi̇nde hatalı sonuçların değerlendi̇rilmesi. Ankara: Pegem Yayınevi.

Datta P, Dasgupta A. Cross-reactivity of fosphenytoin in four phenytoin immunoas- says. Clin Chem 1998; 44: 696-697.

Frank EL, Schwarz EL, Juenke J et al. Performance characteristics of fom immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer. Am J Clin Pathol 2002; 118: 124-131.

Parant F, Moulsma M, Gagnieu MC et al. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA). Ther Ding Monit 2005; 27: 457-462.

Datta P. Scurlock D. Dasgupta A. Analytic performance evaluation of a new turbidimetric immunoassay for phenytoin on the ADVIA 1650 analyzer: effect of phenytoin metabolite and analogue. Tlier Drug Monit 2005; 27: 305-308.

Datta P, Dasgupta A. Cross-reactivity of fosphenytoin in four phenytoin immunoas- says. Clin Chem 1998; 44: 696-697.

Frank EL, Schwarz EL, Juenke J et al. Performance characteristics of fom immunoassays for antiepileptic drugs on the IMMULITE 2000 automated analyzer. Am J Clin Pathol 2002; 118: 124-131.

Pippenger CE, Gillen HW. Gas chromatographic analysis for anticonvulsant drugs in biologic fluids. Clin Chem 1969; 15: 582-590.

Rainey PM. Rogers KE, Roberts WL. Metabolite and matrix interference in phe- nytoin immunoassays. ClinChem 1996:42: 1645-1653.

Matzke GR. Sawchuk RJ. Elevated seimn phenytoin concentrations in uremic patient measured by enzyme multiplied immunoassay. Drug Intell Clin Phann 1981;15: 386-388.

Tutor-Crespo MJ, Hermida J, Tutor JC. Phenytoin immunoassay measurements in serum from patients with renal insufficiency: comparison with high-performance liquid chromatography. J Clin Lab Anal 2007; 21: 119-123.

Tutor-Crespo MJ. Hennida J, Tutor JC. Relative proportions of serum carbamaze- pine and its pharmacologically active 10, 11-epoxide derivative: effect of polytherapy and renal insufficiency. Ups J Med Sci 2008; 113: 171-180.

Parant F, Moulsma M, Gagnieu MC, Lardet G. Hydroxyzine and metabolites as a source of interference in carbamazepine particle-enhanced turbidimetric inhibition immunoassay (PETINIA). Ther Ding Monit 2005; 27: 457-462.

Dasgupta A, Tso G, Johnson M, Chow L. Hydroxyzine and cetirizine interfere with the PETINIA carbamazepine assay but not with the ADVIA CENTEUR carba- mazepine assay. Ther Drug Monit 2010; 32: 112-115.

Ainmann H, Vinet B. Accuracy, precision, and interferences of three modified EMIT procedures for determining serum phénobarbital, urine morphine, and urine cocaine metabolite with a Cobas-Fara. Clin Chem 1991; 37: 2139-2141.

Nordt SP. Butalbital cross-reactivity to an EMIT assay for phénobarbital. Ami Phannacother 1997;31:254-255.

Meinardi H. Vander Kleijn E, Meijer JWA. Absoiption and distribution of antiepileptic drugs. Epilepsia 1982; 23: 23-26.

Yuan R, Venitz J. Effect of chronic renal failure on the disposition of highly hepati- cally metabolized drugs. Int J Clin Pharmacol 2000; 38: 245-253.

Gulyassy PF, Jarrard E, Stanfel L. Roles of hippurate and indoxyl sulfate in the unpaired ligand binding by azotemic plasma. Adv Exp Med Biol 1987; 223: 55-58.

Ghuman J, Zmiszain P, Petitpas I et al. Structural basis of drug- binding specificity of human serum albumin. J Mol Biol 2005; 353: 38-52.

Zielmaim S, Mielck F, Kahl R et al. A rational basis for the measure- ment of free phenytoin concentration in critically ill trauma patients. Tlier Dnig Monit 1994; 16:139-144.

Gidal BE, Collins DM, Beinlich BR. Apparent valproic acid neurotoxicity in a hypoalbuminémie patient. Ami Phannacother 1993; 27; 32-35.

Haroldson JA, Kramer LE, Wolff DL et al.Elevated free fr actions of valproic acid in a heart transplant patient with hypoalbuminemia. Ami Phannacother 2000: 34: 183— 187.

de Matt M, van Leeuwen HJ, Edelbroek PM. High unbound fraction of valproic acid in a hypoalbuminémie critically ill patient on renal replacement therapy. Ami Phannacother 2011; 45: el8.

Pennell PB. Antiepileptic ding pharmacokinetics during pregnancy and lactation. Neurology 2003: 61 (Suppl 2): S35-S42.

Dasgupta A, Dennen DA, Dean R et al. Displacement of phenytoin from serum protein carriers by antibiotics: studies with ceftriaxone, nafcillin and sulfamethoxazole. Clin Chem 1991; 37: 98-100.

Bates DE. Herman RJ. Carbamazepine toxicity induced by lopinavir/ritonavir and nelfinavir. Ami Pharmacother 2006; 40: 1190-1194.

Dökmeci İ. (2001). Toksikoloji. 3. Baskı. İstanbul: Nobel Tıp Kitabevi

Curry SC. Medical toxicology. Critical Care Clinics. 1997; (4).